Audited Financial Result for the quarter and year ended 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pentokey Organy reported audited results for FY25 with revenue from operations of Rs 82.62 Lakhs, a sharp drop of about 81% from Rs 439.63 Lakhs in FY24. Total income fell to Rs 129.05 Lakhs from Rs 484.77 Lakhs. Profit after tax declined to Rs 24.55 Lakhs (from Rs 87.25 Lakhs), translating to an EPS of Rs 0.39 vs Rs 1.39 in the prior year. The company operates in a single segment — pharmaceutical trading. The statutory auditor (Verma Mehta & Associates) issued an unmodified (clean) opinion on the financials. The company also disclosed a pending income tax appeal of Rs 171.58 Lakhs for Assessment Year 2015-16.
The steep ~81% revenue collapse is a major red flag for shareholders, indicating significant business shrinkage despite profits being reported. The reliance on other income (interest/dividends from Rs 45.36 Lakhs in cash flow) to stay profitable raises questions about core operating health. A pending tax demand of Rs 171.58 Lakhs is a material contingent liability relative to the company's small equity base.